Boulla LLC: Drug Recall
Recall #D-0084-2025 · 11/04/2024
Class I: Dangerous
Recall Details
- Recall Number
- D-0084-2025
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Boulla LLC
- Status
- Ongoing
- Date Initiated
- 11/04/2024
- Location
- Sacramento, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- Unknown
Reason for Recall
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Product Description
PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com
Distribution Pattern
Nationwide within the United States
Other Recalls by Boulla LLC
- Class I: Dangerous 11/04/2024
- Class I: Dangerous 11/04/2024
- Class I: Dangerous 11/04/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.